Web-Based program aims to ease fear of cancer return
NCT ID NCT07284030
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 6-week online psychoeducation program can improve psychological well-being and quality of life in breast cancer survivors who finished active treatment at least one year ago. Seventy-two women will either join the online program plus standard care or receive standard care alone. The program includes weekly video sessions focused on coping and emotional support.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Feb 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female breast cancer survivors * Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago * Currently in remission (no evidence of active disease) * Age between 18-65 years * Able to read and write Turkish * Access to computer or smartphone with internet connection * Able to participate in online video sessions via Zoom * Willing to provide informed consent Exclusion Criteria: * Current cancer recurrence or metastatic disease * Active psychiatric disorder requiring treatment * Cognitive impairment that prevents participation in online sessions * Currently receiving active cancer treatment (excluding hormonal therapy) * Participation in another psychosocial intervention study * No internet access or inability to use web-based platforms * Male breast cancer patients * Unable to commit to 6-week program schedule
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast - female are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Breast Cancer Outpatient Clinic
RECRUITINGIstanbul, 34740, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?